These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2517634)

  • 41. HDL-cholesterol sparing and APO-B removal in recycled cascade plasmafiltration.
    Busnach G; Brando B; Dal Col A; Perrino ML; Zoppi F; Minetti L
    ASAIO Trans; 1986; 32(1):168-70. PubMed ID: 3096353
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis.
    Hachem H; Favre G; Raynal G; Blavy G; Canal P; Soula G
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):161-6. PubMed ID: 2872262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The content of basic apoproteins A1 and B and lipids in the blood serum of women with type-I and -II diabetes mellitus and ischemic heart disease].
    Madanat AIa; Slavina LS; Perova NV; Metel'skaia VA; Romanovskaia GA
    Probl Endokrinol (Mosk); 1989; 35(4):3-7. PubMed ID: 2513568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased plasma apolipoprotein B levels and blood hyperviscosity in non-insulin-dependent diabetic patients: role in the occurrence of arterial hypertension.
    Solerte SB; Fioravanti M; Patti AL; Fedele P; Schifino N; Melzi D'eril GV; Gorrini M; Ferrari E
    Acta Diabetol Lat; 1987; 24(4):341-9. PubMed ID: 3439403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of lyophilization of serum on the measurement of apolipoproteins A-I and B.
    Marcovina SM; Adolphson JL; Parlavecchia M; Albers JJ
    Clin Chem; 1990 Feb; 36(2):366-9. PubMed ID: 2105863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fasting specimens not required for routine measurement of plasma apolipoproteins A-I and B.
    Hester J; Shephard MD; Walmsley RN; White GH
    Ann Clin Biochem; 1989 Jul; 26 ( Pt 4)():374-5. PubMed ID: 2504103
    [No Abstract]   [Full Text] [Related]  

  • 47. Apovarepsilon(4) allele increases the risk for exercise-induced silent myocardial ischemia in non-insulin-dependent diabetes mellitus.
    Guangda X; Bangshun X; Xiujian L; Yangzhong H
    Atherosclerosis; 1999 Dec; 147(2):293-6. PubMed ID: 10559515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apo C subclasses from non-insulin-dependent diabetic patients--a quantitative comparison with control subjects.
    Venkatesan S; Imrie H; Read S; Halliday D
    Biochem Soc Trans; 1995 May; 23(2):278S. PubMed ID: 7672305
    [No Abstract]   [Full Text] [Related]  

  • 49. Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions.
    Wägner AM; Sánchez-Quesada JL; Pérez A; Rigla M; Cortés M; Blanco-Vaca F; Ordóñez-Llanos J
    Clin Chem; 2000 Nov; 46(11):1830-2. PubMed ID: 11067819
    [No Abstract]   [Full Text] [Related]  

  • 50. [High density lipoprotein-cholesterol and its subclasses in relation to insulin level in NIDDM].
    Tian HM; Liang JZ
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Jun; 19(2):189-92. PubMed ID: 3058574
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of protein measurements on standardization of assays of apolipoproteins A-I and B1.
    Henderson LO; Powell MK; Smith SJ; Hannon WH; Cooper GR; Marcovina SM
    Clin Chem; 1990 Nov; 36(11):1911-7. PubMed ID: 2242569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ascorbic acid, HDL cholesterol, and apolipoprotein A-I in an elderly Chinese population in Boston.
    Dallal GE; Choi E; Jacques P; Schaefer EJ; Jacob RA
    J Am Coll Nutr; 1989 Feb; 8(1):69-74. PubMed ID: 2494247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 54-year-old diabetic man with low serum cholesterol.
    Turk U; Basol G; Barutcuoglu B; Sahin F; Habif S; Tarugi P; Bayindir O
    Clin Chem; 2012 May; 58(5):826-9. PubMed ID: 22544856
    [No Abstract]   [Full Text] [Related]  

  • 54. Preparation of lyophilized human serum based reference materials with graded levels of apolipoproteins A-I and B.
    Henderson LO; Hazlehurst JS; Taylor L; Hannon WH
    Clin Biochem; 1988 Aug; 21(4):219-23. PubMed ID: 3136957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased apolipoprotein A-I and B content in plasma of individuals with sickle cell anemia.
    Sasaki J; Waterman MR; Cottam GL
    Clin Chem; 1986 Jan; 32(1 Pt 1):226-7. PubMed ID: 3079682
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimation of serum apolipoprotein B by a modified homogeneous assay for HDL-cholesterol.
    Sampson ML; Csako G; Remaley AT
    Clin Chem; 2000 Jun; 46(6 Pt 1):869-71. PubMed ID: 10839781
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.
    Mount JN; Kearney EM; Rosseneu M; Slavin BM
    J Clin Pathol; 1988 Apr; 41(4):471-4. PubMed ID: 3366936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein A-I concentrations in serum: a pragmatic approach to assessing risk of heart disease.
    Lippi U; Bertolini D; Graziani MS
    Clin Chem; 1990 Apr; 36(4):701. PubMed ID: 2108831
    [No Abstract]   [Full Text] [Related]  

  • 59. Apolipoprotein B is an independent risk factor for microalbuminuria in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Diabetes Care; 2003 Oct; 26(10):2965-6. PubMed ID: 14514620
    [No Abstract]   [Full Text] [Related]  

  • 60. [The content of apolipoproteins in blood M and parameters of lipid metabolism in population of North Polar regions and Southern regions of Caucasus].
    Bichkaeva FA; Kokoev TI; Dzhioeva TsG; Dzhabieva ZA; Volkova NI; Tret'iakova TV; Vlasova TS
    Klin Lab Diagn; 2013 Jan; (1):25-7. PubMed ID: 23807990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.